Contemporary Concepts in Noncellular Rejection

Heart Failure Clinics

Volumn 3, Issue 1, 2007, Pages 11-15

  Kobashigawa, Jon A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HEPARIN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

CARDIAC GRAFT REJECTION; CARDIOGENIC SHOCK; DIAGNOSTIC PROCEDURE; DRUG MEGADOSE; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART MUSCLE BIOPSY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PLASMAPHERESIS; REVIEW; SEROLOGY;

ENDOTHELIUM, VASCULAR; GRAFT REJECTION; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION;

EID: 34249743216     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2007.02.006     Document Type: Review

References (29)

1. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
2. Kobashigawa J.A., Miller L.W., Russell S.D., et al. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am J Transplant 6 (2006) 1377-1386
3. Mills R.M., Naftel D.C., Kirklin J.K., et al. Heart transplant rejection with hemodynamic compromise: a multiinstitutional study of the role of endomyocardial cellular infiltrate. J Heart Lung Transplant 16 (1997) 813-821
4. Michaels P.J., Fishbein M.C., and Colvin R.B. Humoral rejection of human organ transplants. Seminars in Immunopathology 25 (2003) 119-140
5. Hammond E.H., Yowell R.L., Nunoda S., et al. Vascular (humoral) rejection in heart transplantation: pathologic observation and clinical complications. J Heart Transplant 8 (1989) 430-443
6. Takemoto S., Zeevi A., Feng S., et al. A national conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 4 (2004) 1033-1041
7. Rose E.A., Pepino P., Barr M.L., et al. Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant 11 (1992) S120-S123
8. Lones M.A., Czer L.S.C., Trento A., et al. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients. J Heart Lung Transplant 14 (1995) 151-162
9. Michaels P.J., Espejo M., Kobashigawa J., et al. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 22 (2003) 58-69
10. Przybylowski P., Balogna M., Radovancevic B., et al. The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients. Transplantation 67 (1999) 258-262
11. Aziz S., Hassantash S.A., Nelson K., et al. The clinical significance of flow cytometry cross matching in heart transplantation. J Heart Lung Transplant 17 (1998) 686-692
12. Wu G.D., Jin Y.S., Salazar R., et al. Vascular endothelial cell apoptosis induced by anti donor non-MHC antibodies: a possible injury pathway contributes to chronic allograft rejection. Transpl Immunol 21 (2002) 1174-1187
13. Reed E.F., Demetris A.J., Hammond E., Itescu S., et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 25 (2006) 153-159
14. Barr M.L., Cohen D.J., Benvenisty A.L., et al. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts. Transplant Proc 25 (1993) 262-264
15. Ma H., Hammond E.H., Taylor D.O., et al. The repetitive histologic pattern of vascular cardiac allograft rejection. Increased incidence associated with longer exposure to prophylactic murine monoclonal anti-CD3 antibody (OKT3). Transplantation 62 (1996) 205-210
16. Taylor D.O., Yowell R.L., Kfoury A.G., et al. Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection. J Heart Lung Transplant 19 (2000) 518-521
17. Behr T.M., Feucht H.E., Richter K., et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 8 (1999) 904-912
18. Labarrere C.A. Anticoagulant factors as predictors of transplant associated coronary artery disease. J Heart Lung Transplant 19 (2000) 623-633
19. Chantranuwat C., Qiao J.H., Kobashigawa J., et al. Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft endomyocardial biopsies: comparison to frozen tissue immunofluorescence. Appl Immunohistochem Mol Morphol 12 (2004) 166-171
20. Baldwin III W.M., Samaniego-Picota M., Kasper E.K., et al. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation 68 (1999) 894-900
21. Ratkovec R.M., Hammond E.H., O'Connell J.B., et al. Outcome of cardiac transplant recipients with a positive donor-specific crossmatch-preliminary results with plasmapheresis. Transplantation 54 (1992) 651-655
22. Jordan S.C., Quartel A.W., Czer L.S.C., et al. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 66 (1998) 800-805
23. Mentzer R.M., Jahania M.S., Lasley R.D., et al. Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. Transplantation 65 (1998) 109-113
24. Rose M.L., Smith J., Dureau G., et al. Mycophenolate mofetil decreases antibody production after cardiac transplantation. J Heart Lung Transplant 21 (2002) 282-285 Discusses therapy of rejection
25. Oliven A., and Shechter Y. Extracorporeal photopheresis: a review. Blood Rev 15 (2001) 103-108
26. Crespo-Leiro M.G., Veiga-Barreiro A., Domenech N., et al. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis. Am J Transplant 5 (2005) 2560-2564
27. Veiga Barreiro A., Crespo Leiro M., Domenech Garcia N., et al. Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: incidence and management. Transplant Proc 36 3 (2004) 778-779
28. Keren A., Hayes H.M., and O'Driscoll G. Late humoral rejection in a cardiac transplant recipient treated with the anti-CD20 monoclonal antibody rituximab. Transplant Proc 38 5 (2006) 1520-1522
29. Patel J.K., Kawano J., Wu G.W., et al. Efficacy of photopheresis of recurrent/refractory humoral and cellular rejections in heart transplant patients. Am J Transplant 6 (2006) 146-147